Back

The Drug-Induced Respiratory Disease Website and App

XVI.ab

XVI - Imaging

Imaging: Cavitating/cavitary lung nodule, mass or nodules (see also Iq, XIs, XIIi, XVIaa and XVIIp)

Last update 08/01/2021

See also under pneumatoceles. The diagnosis of drug-induced tumoral cavitation, septic embolism and cavitating rheumatoid nodules (nodulosis) in RA patients needs be entertained (See under Iq)

Causative drugs

16

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

Abused drugs/substances (illicit-, street drugs - IV/inhaled)
I.c
I.e
I.j
I.m
I.s
I.t
II.a
II.b
III.a
IV.a
IV.f
IV.g
V.f
V.q
V.ab
VI.b
VI.c
VI.g
VI.i
VI.j
VI.r
VI.t
VII.h
VII.i
VIII.c
VIII.d
VIII.ai
IX.a
IX.s
IX.ah
X.m
X.u
X.ac
X.bb
XI.b
XI.g
XI.j
XI.n
XII.g
XII.i
XII.v
XV.q
XV.s
XV.v
XV.ag
XV.al
XVI.d
XVI.u
XVI.v
XVI.ab
XVI.ae
XVI.af
XVI.ai
XVII.a
XVII.b
XVII.g
XVII.p
XVII.s
XVII.u
XVII.al
XVIII.t
XVIII.u
XVIII.x
Amiodarone
I.a
I.b
I.c
I.d
I.e
I.f
I.g
I.h
I.k
I.l
I.s
I.u
I.w
I.z
I.aa
I.ao
I.at
I.ax
I.ay
II.b
II.l
III.a
III.c
IV.a
IV.d
IV.r
V.a
V.c
V.d
V.t
VI.a
VI.i
VIII.a
IX.a
IX.d
IX.ai
X.d
X.f
X.q
XI.c
XI.f
XII.a
XII.c
XII.e
XII.l
XII.n
XII.p
XII.t
XII.af
XII.au
XV.a
XV.b
XV.c
XV.d
XV.f
XV.g
XV.h
XV.i
XV.j
XV.k
XV.m
XV.o
XV.r
XV.ao
XV.bt
XV.co
XV.dc
XVI.b
XVI.i
XVI.j
XVI.n
XVI.s
XVI.w
XVI.aa
XVI.ab
XVI.ay
XVI.az
XVI.bj
XVI.bq
XVI.bt
XVI.bx
XVI.ca
XVII.e
XVIII.b
XVIII.j
XVIII.k
XVIII.p
XIX.a
XIX.b
XIX.c
XIX.e
XIX.f
XIX.m
XIX.p
XXVIII.c
Bevacizumab
I.b
II.b
III.a
III.c
III.g
III.h
III.k
IV.a
V.f
VI.a
VI.b
VIII.o
VIII.r
VIII.ab
X.f
X.s
XI.s
XII.a
XII.e
XII.f
XII.g
XII.ai
XII.aj
XII.at
XVI.ab
XVI.af
XVI.bf
XXVII.f
Bleomycin
I.a
I.b
I.c
I.d
I.f
I.g
I.k
I.l
I.p
I.v
I.w
II.b
II.t
V.f
V.p
V.z
VI.c
VI.f
VII.e
VII.h
XI.b
XI.c
XV.a
XV.b
XV.c
XV.d
XV.f
XV.h
XV.i
XV.j
XV.l
XV.ax
XV.be
XV.bf
XVI.a
XVI.b
XVI.e
XVI.k
XVI.w
XVI.ab
XVI.af
XVI.bl
XVIII.j
XIX.b
XXIV.a
XXIV.b
Carbamazepine
I.a
I.b
I.c
I.d
I.e
I.k
I.l
II.a
II.b
IV.a
V.a
V.d
VII.a
VII.b
X.a
X.d
X.m
XII.a
XII.c
XII.d
XII.l
XII.s
XIII.b
XV.a
XV.b
XV.c
XV.e
XVI.ab
Catheter coating
V.a
VI.g
X.q
X.s
XV.q
XV.ag
XV.bz
XVI.w
XVI.ab
XVI.an
Chemicals
I.a
I.b
I.d
I.j
I.af
II.a
II.b
III.a
III.b
IV.c
IV.n
IV.q
V.a
VIII.c
VIII.h
X.m
X.u
X.ac
XI.o
XII.m
XIV.a
XIV.b
XV.x
XVI.ab
XVII.p
Chemotherapy, antineoplastic
I.a
I.b
I.c
I.d
I.f
I.g
I.h
I.k
I.l
I.m
I.n
I.v
I.w
I.x
I.y
I.aa
I.ad
I.ao
I.au
II.a
II.b
II.c
II.d
III.a
IV.a
IV.k
V.a
V.f
V.ab
VI.b
VI.c
VI.f
VII.a
VII.h
VIII.a
VIII.t
IX.f
IX.j
IX.o
X.c
X.d
X.f
X.g
X.k
X.n
XI.b
XI.k
XI.s
XII.a
XII.b
XII.c
XII.e
XII.f
XII.g
XII.l
XII.s
XII.ai
XII.bl
XIII.a
XIII.b
XIII.d
XV.c
XV.d
XV.f
XV.i
XV.l
XV.ak
XV.am
XV.ba
XVI.ab
XVI.af
XVI.bf
XVI.bl
XVI.bw
XVII.b
XVII.c
XVII.e
XVII.g
XVII.j
XVII.r
XVII.af
XIX.g
Cryobiopsy (transbronchial pulmonary-; TBLB TBLCB)
I.y
III.c
III.e
III.h
III.l
V.f
XVI.ab
XVI.af
XVI.cb
Hydrocarbons (petrochemicals: petroleum, petrolatum, paraffin, vaseline, naphta, jet fuel (kerosene), Diesel, gasoil), ointments, salad oil, variegated oils, butter). Aspirated
I.b
I.g
I.j
I.z
I.ae
I.af
I.ag
II.b
III.a
III.c
IV.k
V.a
VIII.d
XI.b
XI.o
XIV.a
XV.as
XVI.b
XVI.f
XVI.k
XVI.ab
XVI.ah
XVI.cb
XVII.p
XIX.a
XIX.h
Lenvatinib
I.b
V.f
VI.a
XVI.ab
Nivolumab
I.a
I.b
I.c
I.d
I.e
I.f
I.h
I.ad
I.aj
II.b
II.d
III.g
III.j
III.m
IV.a
IV.c
IV.j
IV.n
IV.y
IV.ab
IV.al
V.a
V.m
VI.b
VIII.t
VIII.ba
IX.a
IX.d
IX.h
IX.r
IX.y
IX.ab
X.a
X.d
X.f
X.g
X.j
X.k
X.m
X.n
X.s
X.u
X.ac
X.ay
XI.ar
XI.bn
XII.c
XII.d
XII.g
XII.n
XII.s
XII.ai
XII.ax
XV.c
XV.d
XV.g
XV.x
XV.bb
XV.cv
XVI.i
XVI.v
XVI.w
XVI.ab
XVI.af
XVI.ai
XVII.a
XVII.c
XVII.g
XVII.aj
XIX.a
XIX.b
XIX.c
XXVII.b
XXVII.e
Paraffin-Vaseline-Oil-Lipids (Mineral or other) p.o./inhaled/aspirated
I.b
I.g
I.j
I.k
I.s
I.z
I.ap
II.b
III.c
IV.w
VII.o
X.e
XIII.a
XV.e
XV.h
XV.p
XV.q
XV.dd
XVI.a
XVI.b
XVI.f
XVI.i
XVI.k
XVI.n
XVI.r
XVI.w
XVI.z
XVI.ab
XVI.az
XVI.bc
XVII.h
XVIII.r
XIX.a
XIX.h
XIX.j
XXIV.f
Radiation therapy (early effects)
I.a
I.b
I.c
I.d
I.v
I.y
I.ab
I.ac
II.b
V.a
V.h
VIII.c
IX.h
XI.s
XII.k
XV.a
XV.b
XV.c
XV.d
XV.f
XV.h
XV.i
XVI.ab
XVI.bl
XIX.a
XIX.c
Radiation therapy (medium term & late effects)
I.c
I.d
I.g
I.h
I.o
I.v
I.x
II.b
III.c
IV.k
IV.m
V.a
V.b
V.c
V.f
V.h
V.l
V.m
V.t
VI.c
VI.t
VI.ab
VII.d
VII.i
VII.j
VII.l
VIII.c
VIII.j
VIII.r
VIII.t
VIII.ab
VIII.au
VIII.av
IX.a
IX.aj
XI.g
XI.l
XI.r
XI.ac
XI.av
XI.bk
XII.a
XII.b
XII.f
XII.g
XII.k
XII.o
XII.s
XII.ad
XII.ak
XII.an
XII.bc
XII.bz
XIII.a
XIII.d
XIII.e
XIII.j
XIII.l
XIII.m
XV.f
XV.l
XVI.ab
XVI.bi
XVI.bj
XVI.bl
XXVII.a
XXVII.b
XXVII.e
Loading more…